Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Product/Service, Economic News/Analysis

Spend on Car Rentals More than Doubles Annually in Q2 2023, Emburse SpendSmart Reports


Emburse, a leader in travel and expense (T&E) management, announced today the results of its Q2 2023 SpendSmart Travel Trends report. This quarterly report tracks how much organizations spend on business travel, as well as trends for booking volume and trip length, and compares it to the previous year and the previous quarter.

In Q2 2023, business travel measures changed as follows:

Car rental companies reduced their fleets during the pandemic lockdown and have not yet fully restocked. When the pandemic emergency was declared over in May 2023, a boom in demand for car rentals drove prices up exponentially, which is reflected by the data released today. This leaves corporate travel managers in a position to make difficult decisions about how to guide their employees for business trip transportation.

"The state of the car rental market is a great example of why we are making moves like our recent acquisition of TRIPBAM, which ensures that companies are getting the best rates on rental cars, hotels and airfare," said Eric Friedrichsen, CEO of Emburse. "Business travel continues to rebound, but the economy we are in is different from that of 2019 or even last year. While our customers are lifting travel bans, they are still looking to maximize the value they get for each trip. And we're helping them by reducing the cost side of the ROI calculation."

Emburse plans to continue monitoring these figures and updating them quarterly. The next SpendSmart Travel Trends report will examine Q3 2023 and will be available in October.

About Emburse

Emburse is the global leader in spend optimization. Our expense, travel management, purchasing and accounts payable, and payments solutions are trusted by more than 12 million business professionals, including CFOs, finance teams, and travelers. More than 18,000 organizations in 120 countries, including FORTUNE 100 corporations, high-growth startups, public sector agencies, and nonprofits, count on our intelligent automation, sophisticated analytics, and unmatched spend control to streamline processes, increase spend visibility, enhance compliance, and deliver positive financial outcomes.

Our mission is to humanize work by eliminating manual, time-consuming tasks, so our customers and their teams can focus on what matters most in their personal and professional lives.

For more information on Emburse, visit emburse.com, or follow our social channels at @Emburse.

Methodology

The data in the Emburse Business Travel Index represents 150,000 individual transactions made by travel management companies using Emburse's expense management platform for business travel expenses. It reflects the months of April, May, and June collectively (Q2) for the years 2019, 2020, 2021, 2022, and 2023.


These press releases may also interest you

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...

at 03:58
Allied Market Research published a report, titled, "Forex Brokers Market by Counterparty (Reporting Dealers, Financial Institutions, and Non-financial Customers) and Type (Currency Swap, Outright Forward &...

at 03:45
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it will host a conference call on Thursday, May 23, 2024 at 4:30 p.m. ET to discuss and answer...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

16 mai 2024
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...



News published on and distributed by: